Leading the way in innovation for over 50 years, we build greater futures for businesses across multiple industries and 131 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
You have these already downloaded
We have sent you a copy of the report to your email again.
Shaping a resilient business strategy can help a medical device business to adapt to any new situations in future. While every company tries to optimize their operations, they tend to reach the point of strategic convergence without much differentiation. There are various aspects of business strategies and models that MedTech companies should focus on to not just adapt to new situations but also maintain the much-needed competitive advantage.
This whitepaper talks about the uniqueness of COVID-19 impact on MedTech industry and the ways it has necessitated thinking in multiple dimensions, establishing strong partnerships and developing a resilient eco-system. It offers a point of view on diversification and consolidation, differentiations for solution providers versus a product seller, innovation, role of advanced technologies, supply chain alternatives, new avenues of healthcare delivery and the enablement of business transformation through digital technology.
Want to deliver memorable experiences to your customers?Talk to our experts
Find out more